These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 31995840

  • 1. Insulin Glargine in Critically ill Patients: Once/Day versus Twice/Day Dosing.
    Fox MA, Perry MC, Liu-DeRyke X.
    Pharmacotherapy; 2020 Mar; 40(3):186-190. PubMed ID: 31995840
    [Abstract] [Full Text] [Related]

  • 2. HYPOGLYCEMIA RATES AFTER RESTRICTION OF HIGH-DOSE GLARGINE IN HOSPITALIZED PATIENTS.
    Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM.
    Endocr Pract; 2016 Dec; 22(12):1393-1400. PubMed ID: 27540877
    [Abstract] [Full Text] [Related]

  • 3. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR, Lurie A, Baldwin D.
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [Abstract] [Full Text] [Related]

  • 4. COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES.
    Galindo RJ, Davis GM, Fayfman M, Reyes-Umpierrez D, Alfa D, Peng L, Tamler R, Pasquel FJ, Umpierrez GE.
    Endocr Pract; 2017 Sep; 23(9):1059-1066. PubMed ID: 28683239
    [Abstract] [Full Text] [Related]

  • 5. A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
    Pasquel FJ, Lansang MC, Khowaja A, Urrutia MA, Cardona S, Albury B, Galindo RJ, Fayfman M, Davis G, Migdal A, Vellanki P, Peng L, Umpierrez GE.
    Diabetes Care; 2020 Jun; 43(6):1242-1248. PubMed ID: 32273271
    [Abstract] [Full Text] [Related]

  • 6. BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA.
    Bueno E, Benitez A, Rufinelli JV, Figueredo R, Alsina S, Ojeda A, Samudio S, Cáceres M, Argüello R, Romero F, Echagüe G, Pasquel F, Umpierrez GE.
    Endocr Pract; 2015 Jul; 21(7):807-13. PubMed ID: 26121460
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Efficacy and Safety of Insulin Detemir and Insulin Glargine in Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Trial.
    Zhang T, Lin M, Li W, Fan X, Du T, Zhao Y, Zhang X.
    Adv Ther; 2016 Feb; 33(2):178-85. PubMed ID: 26809253
    [Abstract] [Full Text] [Related]

  • 8. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.
    Demma LJ, Carlson KT, Duggan EW, Morrow JG, Umpierrez G.
    J Clin Anesth; 2017 Feb; 36():184-188. PubMed ID: 28183563
    [Abstract] [Full Text] [Related]

  • 9. Risk of Hypoglycemia During Insulin Infusion Directed by Paper Protocol Versus Electronic Glycemic Management System in Critically Ill Patients at a Large Academic Medical Center.
    Rabinovich M, Grahl J, Durr E, Gayed R, Chester K, McFarland R, McLean B.
    J Diabetes Sci Technol; 2018 Jan; 12(1):47-52. PubMed ID: 29251064
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency.
    Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, Emanuele MA, Glossop V, Smallwood K, Molitch M.
    Diabetes Care; 2012 Oct; 35(10):1970-4. PubMed ID: 22699288
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of regular versus glargine insulin in stable critical care patients receiving parenteral nutrition: a randomized controlled trial.
    Oghazian MB, Javadi MR, Radfar M, Torkamandi H, Sadeghi M, Hayatshahi A, Gholami K.
    Pharmacotherapy; 2015 Feb; 35(2):148-57. PubMed ID: 25689245
    [Abstract] [Full Text] [Related]

  • 14. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C, Ditton G, Russell GB, Aloi J.
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of exenatide twice daily vs insulin glargine as add-on therapy to oral antidiabetic agents in patients with type 2 diabetes in China.
    Gu S, Wang X, Qiao Q, Gao W, Wang J, Dong H.
    Diabetes Obes Metab; 2017 Dec; 19(12):1688-1697. PubMed ID: 28452095
    [Abstract] [Full Text] [Related]

  • 17. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA, Mulia HA, Azzam A, Amin T.
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blood glucose response to rescue dextrose in hypoglycemic, critically ill patients receiving an insulin infusion.
    Murthy MS, Duby JJ, Parker PL, Durbin-Johnson BP, Roach DM, Louie EL.
    Ann Pharmacother; 2015 Aug; 49(8):892-6. PubMed ID: 25986006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.